Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin vs Caspofungin in Esophageal Candidiasis
NCT00665639Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2004
- Primary completion
- Dec 2004
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial of micafungin in esophageal candidiasis (3 arms), sponsored by Astellas Pharma. Primary endpoint: Comparative incidence of success. Started Jun 2004; status: completed.
02
Drugs
micafungin
03
Conditions
esophageal candidiasis
Beyond the preview
Go deeper on NCT00665639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00665639.